ABSTRACT
The COVID-19 pandemic has led to an increased risk of developing Type 2 Diabetes in patients with no prior history of the disease. In this systematic review, we aim to investigate the association between COVID-19 and newly diagnosed Type 2 Diabetes and identify the potential risk factors and underlying mechanisms of diabetes development in COVID-19 patients. Investigating the occurrence of diabetes following coronavirus infection was the study's goal. Out of the total 2700 cases, the mildly symptomatic (1628, 60.30%) and moderately symptomatic (815, 30.18%) patients received OPD treatment and experienced alleviation in 3-7 days;none of them required hospitalisation. Out of 2700 cases, 257 (or 9.52%) required hospitalisation due to serious illness. Our analysis shows that COVID-19 is associated with a higher risk of newly diagnosed Type 2 Diabetes, and that factors such as inflammation, insulin resistance, and genetic predisposition may contribute to the development of diabetes in COVID-19 patients. This study confirms the necessity of active glucose monitoring in hospitalised, critically unwell SARS-CoV-19-infected patients. [ FROM AUTHOR] Copyright of Journal of Cardiovascular Disease Research (Journal of Cardiovascular Disease Research) is the property of Journal of Cardiovascular Disease Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)